Dialysis is enhanced by using nanoclay sorbents to better absorb body wastes in a flow-through system. The nanoclay sorbents, using montmorillonite, bentonite, and other clays, absorb significantly more ammonium, phosphate, and creatinine, and the like, than conventional sorbents. The montmorillonite, the bentonite, and the other clays may be used in wearable systems, in which a dialysis fluid is circulated through a filter with the nanoclay sorbents. Waste products are absorbed by the montmorillonite, the bentonite, and the other clays and the dialysis fluid is recycled to a patient's peritoneum. Using an ion-exchange capability of the montmorillonite, the bentonite, and the other clays, waste ions in the dialysis fluid are replaced with desirable ions, such as calcium, magnesium, and bicarbonate. The nanoclay sorbents are also useful for refreshing a dialysis fluid used in hemodialysis and thus reducing a quantity of the dialysis fluid needed for the hemodialysis.

A composite sorbent composition comprising a polymeric adsorbent; and an extractant having the formula (I), or hydrate in thereof, wherein X is O or S, A1 and A2 are each independently —C(O)— or —C(R′)(R″)— wherein R′, and R″ are each independently hydrogen, halogen, hydroxyl, cyano, nitro, amino, —CHO, —COOH, C1-12 alkyl, C1-4 alkoxy, C1-4 alkylamino, C1-2 haloalkyl, C1-2 haloalkoxy, C1-12 cycloalkyl, C6-12 aryl, C7-13 arylalkyl, C3-12 heteroaryl, C1-12 heteroalkyl, or C4-12 heteroarylalkyl, Z is a covalent bond, —S—, —O—, —SO2—, —SO—, —P(R)(═O)—, —NR—, -C(O)-, -C(O)NH-, —C(═N—R)—, or —C(R′)(R″)— wherein R, R′, and R″ are each independently hydrogen, halogen, hydroxyl, cyano, nitro, amino, —CHO, —COOH, —C(O)NH2, C1-12 alkyl, C1-12 alkoxy, C1-12 alkylamino, C1-4 haloalkyl, C1-4 haloalkoxy, C4-12 cycloalkyl, C6-12 aryl, C7-13 arylalkyl, C3-12 heterocycloalkyl, C3-12 heteroaryl, C1-12 heteroalkyl, or C4-12 heteroarylalkyl, and R1 and R2 are each independently hydrogen, halogen, hydroxyl, cyano, nitro, amino, or a substituted or unsubstituted monovalent C1-40 hydrocarbon.

##STR00001##

Provided are a toxin separator and the like which are capable of selectively separating toxin present in a biological fluid by binding to protein, from the toxin and the protein. The toxin separator of the present invention also includes activated carbon of which a pore volume of pores having a pore diameter from 1.4 to 35 nm as measured by a nitrogen adsorption method is 0.06 cm.sup.3/g or greater.

Apparatus and method for photo-chemical oxidation are disclosed herein. In one embodiment, a dialysis fluid regeneration system includes: a nanostructured anode; a source of light configured to illuminate the anode; and a cathode that is oxygen permeable.

Various examples are provided related to dialysate-free renal replacement. In one example, a dialysate-free continuous renal replacement system includes a blood filtration stage (e.g., in a microfluidic membrane module). The blood filtration stage can include a blood filtration membrane configured to that can provide a filtered fluid by renal filtration of blood passing through the blood filtration stage at arterial pressure. The continuous renal replacement system can also include a salt recovery stage and a water recovery stage. The salt recovery stage can recover ions through separation from the blood filtration stage. The water recovery stage can separate water from the desalted fluid from the salt recovery stage, where the water is combined with the separated ions and reinfused into the blood after passing through the blood filtration stage.

The described technology may include treatment processes to increase the red blood cell (RBC) population of individuals, particularly chronic kidney disease (CKD) patients with renal anemia, by reducing an amount of Piezo1 chemical agonists in the blood of patients. In one embodiment, a method of treating a patient with renal anemia may include increasing RBC lifespan of an RBC population of the patient via reduction of a Piezo1 channel activation duration of at least a portion of the RBC population by reducing an amount of a target uremic compound in the blood of the patient, the target uremic compound having a form that prolongs the Piezo1 channel activation duration, wherein the amount of the target uremic compound may be reduced via selectively removing at least a portion of the target uremic compound from the blood of the patient. Other embodiments are described.

A blood based solute monitoring system for measuring at least one blood solute species that has a first recirculation flow path in communication with a dialyzer. The first recirculation flow path is configured to allow a fluid to recirculate through a dialyzer such that the concentration of at least one solute species in the fluid becomes equilibrated to the solute species concentration of the blood compartment of the dialyzer. The blood solute monitoring system has at least one sensor to measure a fluid characteristic.

Apparatus and method for photo-chemical oxidation are disclosed herein. In one embodiment, a dialysis fluid regeneration system includes: a nanostructured anode; a source of light configured to illuminate the anode; and a cathode that is oxygen permeable.

A blood based solute monitoring system for measuring at least one blood solute species that has a first recirculation flow path in communication with a dialyzer. The first recirculation flow path is configured to allow a fluid to recirculate through a dialyzer such that the concentration of at least one solute species in the fluid becomes equilibrated to the solute species concentration of the blood compartment of the dialyzer. The blood solute monitoring system has at least one sensor to measure a fluid characteristic.

Apparatus and method for photo-chemical oxidation are disclosed herein. In one embodiment, a method for regenerating a dialysis fluid includes: flowing the dialysis fluid between an anode and a cathode of a dialysis system, where the anode comprises a plurality of nanostructures; illuminating the anode with a source of light; flowing oxygen through the cathode toward the dialysis fluid; and converting urea in the dialysis fluid into CO2, N2 and H2O thereby regenerating the dialysis fluid.